drugset / Trial / NCT00667095

Over Active Bladder Instillation Study - Botox

NCT00667095 ↗

Phase 3 Terminated 25 enrolled Mayo Clinic
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether women with overactive bladder (OAB) who receive direct instillation via a catheter of a Botulinum-A Toxin (Botox) with Dimethyl Sulfoxide (DMSO) solution experience significantly better improvement of their OAB symptoms when compared to a similar group of women with OAB who receive instillation of DMSO only.

Timeline

Start
2008-04
Primary completion
2012-01
Completion
2012-01

Outcome

Met primary endpoint

Stopped: “Study terminated early due to PI's extended medical leave.”

registry analysis (superiority or other test); Botox and DMSO Instillation vs DMSO Instillation; p = 0.024; t-test, 2 sided NCT00667095 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 300 iu Other

Indications